MoneyWorks4Me

Biocon informs about appointment of Additional Director

26 Apr 2013 Evaluate

Biocon has informed that the Board of Directors of the Company at its meeting held on April 25, 2013 has appointed Daniel M Bradbury as an Additional Director of the Company. He will hold office up to the date of ensuing Annual General Meeting, wherein his appointment as a Director will be placed before shareholders for approval.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..